Baldwin Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,035
Closed -$692K 232
2026
Q1
$692K Sell
11,035
-1,750
-14% -$140K 0.08% 131
2025
Q4
$1.22M Sell
12,785
-360
-3% -$35.3K 0.14% 91
2025
Q3
$1.28M Buy
13,145
+675
+5% +$69.9K 0.15% 87
2025
Q2
$1.34M Buy
12,470
+1,870
+18% +$189K 0.16% 84
2025
Q1
$1.07M Buy
10,600
+1,860
+21% +$187K 0.13% 98
2024
Q4
$781K Buy
8,740
+102
+1% +$8.98K 0.1% 113
2024
Q3
$724K Buy
8,638
+913
+12% +$72K 0.09% 130
2024
Q2
$595K Buy
7,725
+200
+3% +$14.6K 0.08% 136
2024
Q1
$515K Buy
7,525
+2,500
+50% +$161K 0.07% 153
2023
Q4
$290K Buy
5,025
+500
+11% +$26.7K 0.05% 176
2023
Q3
$239K Buy
4,525
+410
+10% +$21.5K 0.04% 178
2023
Q2
$223K Buy
+4,115
New +$215K 0.04% 184

Other funds holding BSX

Baldwin Investment Management's BSX Position: Q2 2026 in Review

Baldwin Investment Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 11,035 shares — an estimated $692K sold.

Baldwin Investment Management first reported a position in BSX in Q2 2023 and held it in 12 quarters. The position peaked at $1.34M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Baldwin Investment Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Baldwin Investment Management sold 11,035 Boston Scientific shares in Q2 2026, an estimated $692K.
  • Baldwin Investment Management first reported a position in Boston Scientific in Q2 2023 and held it in 12 quarters.
  • Baldwin Investment Management's Boston Scientific position peaked at $1.34M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Baldwin Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.